Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EVO | Evotec SE

Index- P/E- EPS (ttm)-0.32 Insider Own- Shs Outstand354.37M Perf Week-16.72%
Market Cap3.58B Forward P/E37.81 EPS next Y0.27 Insider Trans- Shs Float354.37M Perf Month-7.77%
Income- PEG- EPS next Q-0.05 Inst Own0.39% Short Float / Ratio0.01% / 0.87 Perf Quarter-8.88%
Sales- P/S- EPS this Y65.40% Inst Trans- Short Interest0.02M Perf Half Y5.37%
Book/sh- P/B- EPS next Y250.00% ROA- Target Price17.60 Perf Year8.39%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range7.80 - 13.49 Perf YTD26.21%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-24.33% Beta1.32
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low30.90% ATR0.44
Employees5067 Current Ratio- Sales Q/Q-1.10% Oper. Margin- RSI (14)30.75 Volatility3.72% 2.86%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume4.73 Prev Close11.50
ShortableYes LT Debt/Eq- EarningsAug 29 BMO Payout- Avg Volume26.08K Price10.21
Recom2.00 SMA20-12.58% SMA50-15.24% SMA200-2.32% Volume123,476 Change-11.22%
Date Action Analyst Rating Change Price Target Change
Jun-23-23Upgrade Morgan Stanley Equal-Weight → Overweight $12 → $16
Jun-16-23Downgrade BofA Securities Buy → Neutral $13
Jun-08-23Upgrade Citigroup Neutral → Buy
Apr-04-23Upgrade Morgan Stanley Underweight → Equal-Weight $11 → $12
Dec-09-22Initiated H.C. Wainwright Buy $12
Nov-16-22Downgrade Deutsche Bank Buy → Hold
Aug-10-22Downgrade Morgan Stanley Overweight → Underweight $23 → $16
Mar-02-22Resumed Cowen Outperform
Jan-07-22Resumed Citigroup Neutral
Aug-29-23 01:20AM
Aug-22-23 08:20AM
Jul-27-23 02:45PM
Jul-11-23 08:00AM
01:50AM Loading…
Jul-05-23 01:50AM
Jun-29-23 02:00AM
Jun-20-23 11:30AM
Jun-05-23 01:50AM
Jun-02-23 02:00AM
May-12-23 06:30PM
May-09-23 02:55PM
Apr-24-23 04:05PM
08:15AM Loading…
Apr-10-23 08:15AM
Apr-07-23 09:20AM
Mar-28-23 05:20AM
Mar-24-23 03:00AM
Mar-21-23 07:10AM
Mar-16-23 03:05AM
Feb-10-23 02:00AM
Feb-09-23 02:00AM
Feb-07-23 02:00AM
Jan-26-23 02:00AM
Jan-10-23 07:00AM
Dec-16-22 03:40AM
Nov-12-22 01:32AM
Nov-10-22 11:51PM
08:00AM Loading…
Nov-09-22 08:00AM
Nov-08-22 11:02PM
Nov-03-22 07:15AM
Nov-02-22 03:00AM
Oct-28-22 03:20AM
Oct-25-22 01:50AM
Oct-18-22 09:03AM
Oct-17-22 07:15AM
Sep-21-22 10:06AM
Sep-20-22 01:50AM
Sep-16-22 09:25AM
Sep-01-22 07:33AM
Aug-25-22 01:50AM
Aug-11-22 01:40AM
Aug-10-22 07:54AM
Aug-04-22 05:30AM
Jul-06-22 01:50AM
Jul-05-22 01:50AM
Jun-22-22 10:45AM
Jun-15-22 10:47AM
Jun-14-22 10:23AM
May-30-22 02:00AM
May-19-22 01:50AM
May-17-22 11:33AM
May-10-22 10:55AM
May-04-22 08:45AM
Apr-25-22 04:03PM
Apr-22-22 09:23AM
Apr-12-22 01:45AM
Apr-08-22 01:55AM
Apr-05-22 08:55AM
Apr-04-22 11:44AM
Mar-21-22 03:00AM
Mar-02-22 01:50AM
Mar-01-22 01:50AM
Feb-04-22 02:44PM
Jan-25-22 01:55AM
Jan-18-22 03:53AM
Jan-11-22 02:00AM
Jan-03-22 01:55AM
Dec-24-21 11:38AM
Dec-16-21 02:00AM
Dec-15-21 10:38AM
Nov-18-21 07:00AM
Nov-11-21 01:30AM
Nov-10-21 02:00AM
Nov-09-21 09:55AM
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.